Skip to content

Pharma's Digital Revolution: AI Stem Cell Prediction to Digital Supply Chains

AI is revolutionising stem cell research. Meanwhile, digital supply chains are becoming more sustainable. Discover these advancements at AUTOMA+ 2025.

There is a pharmacy store and there is a vehicle in front of it and there is a building in the left...
There is a pharmacy store and there is a vehicle in front of it and there is a building in the left corner.

Pharma's Digital Revolution: AI Stem Cell Prediction to Digital Supply Chains

CellVoyant, a biotech company, is harnessing AI and live cell imaging to predict and optimize stem cell differentiation. Meanwhile, Fraunhofer Austria Research GmbH has outlined key action areas for sustainable, resilient supply chains in its 'Shared Logistics Position Paper'. In the digitalizing pharmaceutical sector, anic GmbH's anicomply web application is enabling swift digital publishing of Electronic Batch Record recipes. The upcoming Pharmaceutical Automation and Digitalisation Congress AUTOMA+ 2025 will delve into these advancements and more.

CellVoyant's FateView platform supports real-time, data-driven decisions in drug development by predicting stem cell differentiation. This is made possible by AI and live cell imaging, marking a significant step in the use of digitalization and AI-powered tools in the pharmaceutical sector.

The 'Shared Logistics Position Paper' from Fraunhofer Austria Research GmbH identifies six key action areas for sustainable, resilient, and future-ready supply chains. These include digitalization, data analytics, and collaboration, all of which are becoming increasingly important in the pharmaceutical industry.

anic GmbH's anicomply web application is streamlining operations by enabling digital publishing of Electronic Batch Record recipes within minutes. It integrates electronic signatures and ensures process integrity by applying the four-eyes principle. This is a testament to the transformative power of digital technologies in medicine discovery, development, and delivery.

AUTOMA+ 2025 will explore how diverse digital solutions connect to create a more integrated and future-ready pharmaceutical ecosystem. The Congress will facilitate conversations between experts, innovators, and decision-makers, including Denis Nicklas, Founder and Managing Director of anic GmbH. He will speak about anic's projects and their contribution to transforming the pharmaceutical industry.

From CellVoyant's AI-driven stem cell differentiation prediction to Fraunhofer's sustainable supply chain action areas, and anic GmbH's digital publishing solutions, the pharmaceutical industry is embracing digitalization and AI. The upcoming AUTOMA+ 2025 Congress promises to be a pivotal event in shaping the future of pharmaceutical development, with experts like Denis Nicklas sharing insights on industry-transforming projects.

Read also:

Latest